Suppr超能文献

[5-氟尿嘧啶和左亚叶酸肝动脉灌注化疗对直肠肝转移的长期控制——病例报告]

[Long-term control of rectal liver metastases by hepatic arterial infusion chemotherapy of 5-fluorouracil and l-leucovorin--a case report].

作者信息

Kanayama Teruji, Ishimaru Sumiko

机构信息

Dept of Surgery, Sekitetsukai Tanabe Central Hospital.

出版信息

Gan To Kagaku Ryoho. 2004 Aug;31(8):1257-9.

Abstract

For synchronous liver metastases from rectal cancer, after extirpation of the primary lesion, a transcatheter arterial embolization was postoperatively performed 3 times at 6-month intervals. Metastatic lesions in S1 and S8 resulted in progressive disease at 8 and 13 months postoperatively, and simultaneous sharp elevation of both CEA and CA19-9 levels. Therapy was then changed to hepatic arterial infusion (HAI) chemotherapy combined with 5-fluorouracil and l-leucovorin (17 months postoperatively). S1 and S8 demonstrated CR and PR, respectively, 8 months after initiation of HAI. Correspondingly, both CEA and CA19-9 levels decreased dramatically, and have thereafter remained stable to date without marked elevation 36 months after the start of HAI. These findings suggest that our regimen for HAI chemotherapy may effectively control liver metastases and restrain progression over the long-term, that is, establish "tumor dormancy" as proposed in recent years. Moreover, CEA and CA19-9 played important roles as surrogate markers that reflect the response to metastatic tumors.

摘要

对于直肠癌的同步肝转移,在切除原发灶后,术后每隔6个月进行3次经导管动脉栓塞术。S1和S8的转移灶在术后8个月和13个月出现疾病进展,同时癌胚抗原(CEA)和糖类抗原19-9(CA19-9)水平急剧升高。随后将治疗改为肝动脉灌注(HAI)化疗联合5-氟尿嘧啶和亚叶酸钙(术后17个月)。开始HAI治疗8个月后,S1和S8分别显示完全缓解(CR)和部分缓解(PR)。相应地,CEA和CA19-9水平均显著下降,此后一直保持稳定,自HAI开始36个月以来无明显升高。这些发现表明,我们的HAI化疗方案可能有效控制肝转移并长期抑制疾病进展,即如近年来所提出的建立“肿瘤休眠”状态。此外,CEA和CA19-9作为反映转移性肿瘤反应的替代标志物发挥了重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验